SUBSTITUTED MORPHOLINE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON SAID, METHOD OF DECREASE OF TACHIKININ LEVEL IN TREATMENT OR PROPHYLAXIS OF PHYSIOLOGICAL STATES ASSOCIATED WITH TACHIKININ EXCESS Russian patent published in 1999 - IPC

Abstract RU 2131426 C1

FIELD: organic chemistry, physiology. SUBSTANCE: invention relates to the substituted derivatives of morpholine of the formula (I) where R1,R2 - hydrogen, halogen atom, alkyl, alkoxy-group or CF3; R3 - hydrogen, halogen atom or CF3; R4 - hydrogen atom; R5 - hydrogen atom or 4-fluoro-group; R6 - 5- or 6-membered heterocyclic ring containing 2 or 3 nitrogen atoms possibly substituted with =O, =S, alkyl or ZNR7; Z is C1-4-alkylene; R7 - hydrogen atom, alkyl, C3-7-cycloalkyl or C3-7-cycloalkyl-C1-4-alkyl or C2-4-alkyl substituted with alkoxy- or hydroxyl-group, or its pharmaceutically acceptable salts and a pharmaceutical composition based on their base which shows property of tachikinin antagonists. EFFECT: improved method of synthesis, decrease of tachikinin level. 28 cl, 4 tbl, 106 ex

Similar patents RU2131426C1

Title Year Author Number
SUBSTITUTED MORPHOLINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF COUNTERACTION TO SUBSTANCE P OR INHIBITION OF NEUROKININ-1 RECEPTORS 1995
  • Konrad P. Dorn
  • Dzheffri Dzh. Khejl
  • Mal'Kol'M Makkoss
  • Sander G. Mills
RU2170233C2
SUBSTITUTED HETEROCYCLES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALT, PHARMACEUTICAL COMPOSITION FOR BLOCKADE OF NEUROKININ-1 RECEPTORS IN MAMMALS, METHOD OF BLOCKADE OF NEUROKININ-1 RECEPTORS IN MAMMALS 1993
  • Konrad P.Dorn
  • Dzheffri Dzh.Khejl
  • Mal'Kol'M Mehkkoss
  • Sander Dzh.Millz
  • Tamara Lehdduvakhetti
  • Shrenik K.Shakh
RU2140914C1
PROCESS OF OBTAINING 5-[[2 (R)-[1 (R)-[3,5-BIS(TRIFLUOROMETHYL) PHENYL]ETHOXY]-3(8)-(4-FLUOROPHENYL)-4-MORPHOLINYL]METHYL]-1,2-DIHYDRO-3H-1,2,4-TRIAZOLE-3-ONE 2003
  • Khaffman Mark
  • Kaba Makhmud S.
  • Pehjak Dzhozef F.
  • Khehndz Dehvid
RU2326879C2
DERIVATIVES OF ARYLSULPHONYLSTILBENE FOR TREATMENT OF INSOMNIA AND ASSOCIATED WITH IT DISORDERS 2005
  • Dzhilligan Mira
  • Khamfriz Aleksandr Charl'Z
  • Khant Piter Alan
  • Ladduvakhetti Tamara
  • Makleod Angus Mjurrej
  • Merchant Kevin Dzhon
RU2382766C2
CATECHOL-O-METHYLTRANSFERASE INHIBITORS AND THEREOF APPLICATION FOR TREATMENT OF PSYCHOTIC DISORDERS 2011
  • Uolkenberg Skott
  • Behrrou Dzhejms K.
  • Kharrison Skott T.
  • Trotter B. Uehsli
  • Nanda Kausik K.
  • Mehnli Piter Dzh.
  • Chzhao Chzhitszjan'
RU2563634C2
TETRAHYDROPYRANYL-CYCLOPENTYL-TETRAHYDROPYRIDOPYRIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY 2003
  • Dziao Richard
  • Morriehllo Gregori
  • Jang Likhu
  • Mojes Kristofer
RU2285004C2
CYCLIC SULPHONAMIDES FOR GAMMA-SECRETASE INHIBITION 2004
  • Dinnell Kevin
  • Kharrison Timoti
  • Nadin Alan Dzhon
  • Ouehns Ehndrju Pehjt
  • Shou Dunkan Ehdvard
  • Vill'Jams Brajan Dzhon
RU2334743C2
INHIBITORS OF CATECHOL-O-METHYLTRANSFERASE AND THEREOF APPLICATION IN TREATMENT OF PSYCHIC DISORDERS 2011
  • Uolkenberg Skott
  • Kharrison Skott T.
  • Behrrou Dzhejms K.
  • Chzhao Chzhitszjan'
  • Melamed Dzheffri
  • Kett Natan
  • Zartman Ehmi
RU2572624C2
PHARMACEUTICALLY ACCEPTABLE SALTS OF 2-{4-[(3S)-PIPERIDIN-3-YL]PHENYL}-2H-INDAZOLE-7-CARBOXAMIDE 2009
  • Fouli Dzhennifer R.
  • Uilson Robert Darrin
RU2495035C2
PROCESS FOR PREPARING INDOLE DERIVATIVES 1993
  • Piter Grenvill Kh'Juton
RU2126003C1

RU 2 131 426 C1

Authors

Rejmond Bejker

Timoti Kharrison

Angus Mjurrej Makled

Ehndrju Pehjt Ouvens

Ehjlin Mehri S'Juard

Kristofer Dzhon Svejn

Martin Richard Till

Dates

1999-06-10Published

1994-12-23Filed